Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Sentinel Lymph Node Biopsy (SLNB) 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Rhabdomyosarcoma 1Recurrence 1Recurent Vulvar Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lymphoma 1Lymphatic Metastasis 1Lung Neoplasms 1HIV Infections 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Eyelid Sebaceous Gland Carcinoma 1Cervical Adenocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Ductal 1Anus Neoplasms 1

Interventions

Technetium Tc 99m Sulfur Colloid 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Eyelid Sebaceous Gland Carcinoma × Sentinel Lymph Node Biopsy × 1 year × Clear all
NCT00832429 2025-07-04

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

M.D. Anderson Cancer Center

Phase 2 Completed
20 enrolled 6 charts

Eyelid Sebaceous Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡